At the 12-month follow-up, VWA was numerically lower in the romosozumab group compared with the teriparatide group (15.05° versus 19.13°), showing a tendency toward statistical significance ( p = 0.054).
← all excerpts
Comparative Radiologic Outcomes of Romosozumab and Teriparatide in Osteoporotic Vertebral Fractures.
1
0.0540
0.0540